Your session is about to expire
← Back to Search
Behavioural Intervention
Brain Stimulation for Opioid Use Disorder
N/A
Recruiting
Led By Abrantes Abrantes, Ph.D.
Research Sponsored by Butler Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Between 21-60 years of age
Be between 18 and 65 years old
Must not have
Current diagnosis of organic brain disorder (e.g., Parkinson's disease, Huntington's disease, multiple sclerosis, intracranial mass/infection, hydrocephalus)
Bipolar, schizophrenia, schizoaffective, or schizophreniform disorder, or current psychosis associated with any disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights
Summary
"This trial will study the effects of brain stimulation on cognitive function and behavior. Phase I showed changes in brain networks after stimulation. Phase II will involve a larger study to look at long-term effects, such
Who is the study for?
This trial is for individuals with Opioid Use Disorder. Participants should have a history of opioid dependency but are currently seeking treatment. The study excludes those who might have other medical conditions that could interfere with the trial or pose risks.
What is being tested?
The study tests if tDCS, a non-invasive brain stimulation technique, can reduce opioid relapse by targeting the brain's cognitive control network. It compares active tDCS to sham (placebo) treatment in a randomized setup to see long-term effects on cravings and relapse.
What are the potential side effects?
tDCs is generally considered safe but may cause mild side effects such as tingling, itching, or discomfort at the electrode sites on the scalp; headache; fatigue; and nausea.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 21 and 60 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have a brain disorder like Parkinson's, Huntington's, MS, or brain infection.
Select...
I have been diagnosed with a serious mental health condition like bipolar or schizophrenia.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in opioid craving
change in EEG oscillatory targets
lower rates of opioid relapse
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: tDCSActive Control1 Intervention
Each participant will undergo 5 consecutive (i.e., business days) sessions of active tDCS delivered to the DLPFC. During each session, participants are engaging in tasks that activate the cognitive control network.
Group II: sham tDCSPlacebo Group1 Intervention
Each participant will undergo 5 consecutive (i.e., business days) sessions of sham tDCS delivered to the DLPFC. During each session, participants are engaging in tasks that activate the cognitive control network.
Find a Location
Who is running the clinical trial?
National Institute on Drug Abuse (NIDA)NIH
2,543 Previous Clinical Trials
3,249,276 Total Patients Enrolled
Butler HospitalLead Sponsor
130 Previous Clinical Trials
16,393 Total Patients Enrolled
Abrantes Abrantes, Ph.D.Principal InvestigatorButler Hospital
Share this study with friends
Copy Link
Messenger